Anti-tumor effects of anti-PD-1 antibody, pembrolizumab, in humanized NSG PDX mice xenografted with dedifferentiated liposarcoma
Bongkum Choi, Joo Sang Lee, Sung Joo Kim, Doo-Pyo Hong, Jae Berm Park, Ki‐Young Lee
Topics & Concepts
Cancer researchImmune systemPembrolizumabAntibodySarcomaImmune checkpointNKG2DImmunotherapySplenocyteCancerCancer immunotherapyMedicineImmunologyBiologyCytotoxic T cellPathologyInternal medicineBiochemistryIn vitroCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCAR-T cell therapy research